159 related articles for article (PubMed ID: 31994285)
1. Performance of simple serum-based tests to exclude cirrhosis prior to hepatitis C treatment in non-hospital settings in Australia.
Burrage L; Zimmerman H; Higgins S; Param K; Orme C; Mitchell J; O'Beirne J
Intern Med J; 2021 Apr; 51(4):533-539. PubMed ID: 31994285
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C.
Papaluca T; Craigie A; McDonald L; Edwards A; MacIsaac M; Holmes JA; Jarman M; Lee T; Huang H; Chan A; Lai M; Sundararajan V; Doyle JS; Hellard M; Stoove M; Howell J; Desmond P; Iser D; Thompson AJ
PLoS One; 2020; 15(11):e0242101. PubMed ID: 33206696
[TBL] [Abstract][Full Text] [Related]
3. Aminotransferase-to-platelet ratio index and Fibrosis-4 index score predict hepatic fibrosis evaluated by transient hepatic elastography in hepatitis C virus-infected hemodialysis patients.
Pestana NF; Equi CMA; Gomes CP; Cardoso AC; Zumack JP; Villela-Nogueira CA; Perez RM
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e260-e265. PubMed ID: 33405422
[TBL] [Abstract][Full Text] [Related]
4. Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study.
Sonneveld MJ; Brouwer WP; Chan HL; Piratvisuth T; Jia JD; Zeuzem S; Liaw YF; Hansen BE; Choi H; Wat C; Pavlovic V; Gaggar A; Xie Q; Buti M; de Knegt RJ; Janssen HLA
Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):538-544. PubMed ID: 30975477
[TBL] [Abstract][Full Text] [Related]
5. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
Yue W; Li Y; Geng J; Wang P; Zhang L
Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
[TBL] [Abstract][Full Text] [Related]
6. Novel non-invasive score to predict cirrhosis in the era of hepatitis C elimination: A population study of ex-substance users in Singapore.
Zhao Y; Thurairajah PH; Kumar R; Tan J; Teo EK; Hsiang JC
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):143-148. PubMed ID: 30558838
[TBL] [Abstract][Full Text] [Related]
7. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection.
Suan MAM; Chan HK; Sem X; Shilton S; Hassan MRA
Sci Rep; 2022 Nov; 12(1):20153. PubMed ID: 36418369
[TBL] [Abstract][Full Text] [Related]
9. Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C.
Gara N; Zhao X; Kleiner DE; Liang TJ; Hoofnagle JH; Ghany MG
Clin Gastroenterol Hepatol; 2013 Mar; 11(3):303-8.e1. PubMed ID: 23142332
[TBL] [Abstract][Full Text] [Related]
10. Performance of noninvasive tools for identification of minimal liver fibrosis in patients with hepatitis B virus infection.
Zhang H; Shi X; Wang L; Zeng Y; Kang X; Huang L
J Clin Lab Anal; 2021 Sep; 35(9):e23960. PubMed ID: 34403524
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
[TBL] [Abstract][Full Text] [Related]
12. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.
Amorim TG; Staub GJ; Lazzarotto C; Silva AP; Manes J; Ferronato Mda G; Shiozawa MB; Narciso-Schiavon JL; Dantas-Correa EB; Schiavon Lde L
Ann Hepatol; 2012; 11(6):855-61. PubMed ID: 23109448
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of transient elastography, point shear wave elastography, APRI and FIB-4 for staging liver fibrosis in chronic viral hepatitis.
Udompap P; Sukonrut K; Suvannarerg V; Pongpaibul A; Charatcharoenwitthaya P
J Viral Hepat; 2020 Apr; 27(4):437-448. PubMed ID: 31799740
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients.
Yunihastuti E; Wicaksana B; Wiraguna A; Hidayah AJ; Amelia F; Natali V; Widhani A; Sulaiman AS; Kurniawan J
BMC Infect Dis; 2020 May; 20(1):372. PubMed ID: 32450844
[TBL] [Abstract][Full Text] [Related]
16. Comparing various cut-offs of aspartate aminotransferase-to-platelet ratio index (APRI) in liver cirrhosis diagnosis among hepatitis C patients in Malaysia.
Mohd Suan MA; Chan HK; Sem XH; Shilton S; Abu Hassan MR
Med J Malaysia; 2021 Nov; 76(6):828-832. PubMed ID: 34806668
[TBL] [Abstract][Full Text] [Related]
17. COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis.
Zachou K; Gabeta S; Shums Z; Gatselis NK; Koukoulis GK; Norman GL; Dalekos GN
Eur J Intern Med; 2017 Mar; 38():83-88. PubMed ID: 28100410
[TBL] [Abstract][Full Text] [Related]
18. Optimized cutoffs of gamma-glutamyl transpeptidase-to-platelet ratio, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 scoring systems for exclusion of cirrhosis in patients with chronic hepatitis B.
Liu X; Li H; Wei L; Tang Q; Hu P
Hepatol Commun; 2022 Jul; 6(7):1664-1672. PubMed ID: 35312182
[TBL] [Abstract][Full Text] [Related]
19. Does Incorporating Change in APRI or FIB-4 Indices Over Time Improve the Accuracy of a Single Index for Identifying Liver Fibrosis in Persons With Chronic Hepatitis C Virus Infection?
Gounder PP; Haering C; Bruden DJT; Townshend-Bulson L; Simons BC; Spradling PR; McMahon BJ
J Clin Gastroenterol; 2018 Jan; 52(1):60-66. PubMed ID: 27875352
[TBL] [Abstract][Full Text] [Related]
20. Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C.
Shiha G; Soliman R; Mikhail NNH; Alswat K; Abdo A; Sanai F; Derbala MF; Örmeci N; Dalekos GN; Al-Busafi S; Hamoudi W; Sharara AI; Zaky S; El-Raey F; Mabrouk M; Marzouk S; Toyoda H
Hepatol Res; 2022 Feb; 52(2):165-175. PubMed ID: 34767312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
